We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3 Top-Ranked Healthcare Mutual Funds Set for Solid Growth
Read MoreHide Full Article
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Fidelity Select Biotechnology Portfolio mainly invests in common stocks of biotechnology-focused companies, including global firms, using fundamental analysis of financial strength, industry position and market conditions. FBIOX operates as a non-diversified fund.
Fidelity Select Biotechnology Portfolio has three-year annualized returns of 19.5%. As of November 2025, FBIOX held 167 issues, with 14.3% of its assets invested in AbbVie.
Vanguard Health Care Fund primarily invests in companies involved in healthcare products and services, including pharmaceutical manufacturers, medical equipment suppliers, hospitals and research organizations. VGHCX advisors may also invest significantly in foreign stocks, and follows a non-diversified investment strategy.
Vanguard Health Care Fund has three-year annualized returns of 9.5%. VGHCX has an expense ratio of 0.33%.
Janus Henderson Global Life Sciences primarily invests in companies with a life sciences focus, allocating a significant portion to that sector, guided by portfolio management’s assessment and maintaining a dedicated exposure to life sciences industries.
Janus Henderson Global Life Sciences has three-year annualized returns of 14.1%. Andrew Acker has been the fund manager of JNGLX since May 2007.
View the Zacks #1 Rank List
Image: Bigstock
3 Top-Ranked Healthcare Mutual Funds Set for Solid Growth
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Below, we share with you three top-ranked Healthcare mutual funds, namely Fidelity Select Biotechnology Portfolio (FBIOX - Free Report) , Vanguard Health Care Fund (VGHCX - Free Report) and Janus Henderson Global Life Sciences (JNGLX - Free Report) . Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.
Fidelity Select Biotechnology Portfolio mainly invests in common stocks of biotechnology-focused companies, including global firms, using fundamental analysis of financial strength, industry position and market conditions. FBIOX operates as a non-diversified fund.
Fidelity Select Biotechnology Portfolio has three-year annualized returns of 19.5%. As of November 2025, FBIOX held 167 issues, with 14.3% of its assets invested in AbbVie.
Vanguard Health Care Fund primarily invests in companies involved in healthcare products and services, including pharmaceutical manufacturers, medical equipment suppliers, hospitals and research organizations. VGHCX advisors may also invest significantly in foreign stocks, and follows a non-diversified investment strategy.
Vanguard Health Care Fund has three-year annualized returns of 9.5%. VGHCX has an expense ratio of 0.33%.
Janus Henderson Global Life Sciences primarily invests in companies with a life sciences focus, allocating a significant portion to that sector, guided by portfolio management’s assessment and maintaining a dedicated exposure to life sciences industries.
Janus Henderson Global Life Sciences has three-year annualized returns of 14.1%. Andrew Acker has been the fund manager of JNGLX since May 2007.
To view the Zacks Rank and the past performance of all Healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>